Magnetic resonance imaging of interstitial laser photocoagulation of normal rat liver: Imaging-histopathological correlation

Interstitial laser thermotherapy for liver tumours

BACKGROUND

Primary hepatocellular carcinoma (HCC) and metastases from colorectal cancer are the most common malignant liver tumours. Surgical resection is the optimum treatment in suitable patients. Interstitial laser thermotherapy (ILT) is gaining acceptance for the treatment of irresectable liver tumours and as a potential alternative to surgery. An understanding of the principles of therapy and review of clinical outcomes may allow better use of this technology.

METHOD

An electronic search using the Medline database was performed for studies on the treatment of hepatic malignancy published between January 1983 and February 2003.

RESULTS

Current information on the efficacy of ILT is based on prospective studies. ILT appears to be a safe and minimally invasive technique that consistently achieves tumour destruction. The extent of destruction depends on the fibre design, delivery system, tumour size and tumour biology. Real-time magnetic resonance imaging provides the most accurate assessment of laser-induced tumour necrosis. In selected patients with HCC and colorectal cancer liver metastases, ILT achieves complete tumour necrosis, provides long-term local control, and improves survival, compared with the natural history of the disease. In addition, ILT has survival benefits for patients with other tumour types, especially those with isolated liver metastases from a breast cancer primary.

CONCLUSION

ILT improves overall survival in specific patients with liver tumours. Advances in laser technology and refinements in technique, and a better understanding of the processes involved in laser-induced tissue injury, may allow ILT to replace surgery as the procedure of choice in selected patients with liver malignancies.

Accuracy of MR phase mapping for temperature monitoring during interstitial laser coagulation (ILC) in the liver at rest and simulated respiration

The chemical shift or proton-resonance frequency (phase mapping) can be used to measure temperature changes. As a subtraction technique, it requires scans at exactly the same location, making it prone to respiration-induced artifacts. The accuracy of magnetic resonance (MR) phase mapping for temperature monitoring of interstitial laser coagulation (ILC) was therefore investigated in two ex vivo models with simulated respiration. MR temperatures were calibrated to interstitially measured temperature. Gradual cooling of a homogenous medium (gel) was monitored for four starting temperatures (room temperature, 40 degrees C, 50 degrees C, and 60 degrees C) during 30 min. Temperature increases were measured during ILC in ex vivo porcine liver with Nd:YAG for 6 min with 5 Watt. Experiments were performed at rest and with simulated respiratory motion (both n = 5). In liver, accuracy did not decrease with respiration simulation (P = 0.32), whereas a significant decline was found in the gel model (P = 0.002). In all experiments a small drift over time was observed between temperature determined with MR and thermoprobes. Correction for temperature-independent phase-shift at a reference location did not enhance agreement. Temperatures could be determined correctly by MR in the moving liver within a range of +/-3.5 degrees C after 6 min of laser application (95% confidence interval), justifying further pre-clinical studies.

Interstitial laser coagulation for hepatic tumours

BACKGROUND

The potential role of interstitial laser coagulation (ILC) for patients with irresectable hepatic tumours is currently being investigated. Since its introduction in 1983 it has evolved into an innovative minimally invasive technique.

METHODS

On the basis of a Medline literature search and the authors' experience, the principles, current state and prospects of ILC for hepatic tumours are reviewed.

RESULTS

Animal studies and early clinical studies have shown the safety and feasibility of ILC. The site of interest can be approached at laparoscopy or percutaneously and treatment is easily repeatable. Recent advances include the use of fibres with a cylindrical diffusing light-emitting tip, the length of which is adaptable to tumour diameter, water-cooled fibre systems, simultaneous multiple fibre application, and hepatic inflow occlusion during laser treatment. ILC allows complete destruction of tumours up to 5 cm in diameter. Currently a limitation is the lack of reliable real-time monitoring of laser-induced effects but progress in magnetic resonance imaging techniques should allow accurate temperature measurements to be obtained rapidly during treatment. However, the actual benefit of ILC in terms of patient survival remains to be investigated.

CONCLUSION

In terms of tools and experience, ILC has now been developed sufficiently to study its effect on survival of patients with irresectable hepatic tumours.